Empagliflozin New
Data Sheet
For research use only. Not for human use.
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
Publications Citing of Biochempartner's Empagliflozin
| CAS No. | 864070-44-0 | Cat. No. | BCP06962 |
| Name | Empagliflozin | ||
| Synonyms | BI 10773; BI10773; BI-10773; CE0108; CS0940; PB23119; VA10802; AJ93046; | ||
| SMILES | C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl | ||
| Chemical Name | |||
| Formula | C23H27ClO7 | M. Wt | 450.91 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Empagliflozin is an orally available competitive inhibitor of sodium-glucose co-transporter 2 (SGLT2; SLC5A2) with antihyperglycemic activity. Upon oral administration, empagliflozin selectively and potently inhibits SGLT2 in the kidneys, thereby suppressing the reabsorption of glucose in the proximal tubule. Inhibition of SGLT2 increases urinary glucose excretion by the kidneys, resulting in a reduction of plasma glucose levels in an insulin-independent manner. Inhibition of SGLT2 in the kidneys also suppresses the renal reabsorption of 1,5-anhydroglucitol (1,5AG). This lowers serum 1,5AG and neutrophil 1,5-anhydroglucitol-6-phosphate (1,5AG6P) levels, which may improve neutropenia and neutrophil dysfunction in patients with glycogen storage disease type Ib (GSD Ib). SGLT2, a transport protein exclusively expressed in the proximal renal tubules, mediates approximately 90% of renal glucose reabsorption from tubular fluid. | ||
Recommend Products
More >
-
Phlorizin dihydrate
Cat. No.：BCP49110
No.：7061-54-3
Product Details -
Enavogliflozin
Cat. No.：BCP48002
No.：1415472-28-4
Product Details -
Licogliflozin
Cat. No.：BCP35901
No.：1291094-73-9
Product Details -
-
Mizagliflozin
Cat. No.：BCP35148
No.：666843-10-3
Product Details -
-
-
Canagliflozin Hydrate
Cat. No.：BCP19353
No.：1809403-05-1
Product Details -
PF-04971729 ((S)-5-oxopyrrolidine-2-carboxylic acid)
Cat. No.：BCP18768
No.：1210344-83-4
Product Details -
Acetoxy Empagliflozin
Cat. No.：BCP17275
No.：915095-99-7
Product Details -
Dapagliflozin propylene glycolate hydrate
Cat. No.：BCP24058
No.：960404-48-2
Product Details -
Remogliflozin etabonate
Cat. No.：BCP16294
No.：442201-24-3
Product Details -
Ipragliflozin L-proline
Cat. No.：BCP28794
No.：951382-34-6
Product Details -
Tofogliflozin hydrate (1:1)
Cat. No.：BCP14576
No.：1201913-82-7
Product Details -
-
Sergliflozin Etabonate
Cat. No.：BCP09291
No.：408504-26-7
Product Details -
Canagliflozin hemihydrate
Cat. No.：BCP09300
No.：928672-86-0
Product Details -
Ertugliflozin
Cat. No.：BCP02525
No.：1210344-57-2
Product Details -
Ipragliflozin
Cat. No.：BCP07718
No.：761423-87-4
Product Details -
Luseogliflozin
Cat. No.：BCP20937
No.：898537-18-3
Product Details
Tags:Empagliflozin supplier,Empagliflozin purchase,Empagliflozin manufacturer,Empagliflozin distributor,Empagliflozin cost,Empagliflozin buy,Empagliflozin for sale